Ft News

Valeant's dose of reality

Informações:

Sinopsis

Valeant was once considered a runaway success story, and one that upended the pharmaceutical sector. A series of crises engulfed the company in recent months, slashing nearly two thirds off its market valuation and forcing the company to tear up its forecasts for 2016. Correspondent David Crow explains. Read the full story at ft.com/valeant. Music: "Brand New Record!" by Steve Combs  See acast.com/privacy for privacy and opt-out information.

Únete Ahora

Únete Ahora

  • Acceso ilimitado a todo el contenido de la plataforma.
  • Más de 30 mil títulos, incluidos audiolibros, podcasts, series y documentales.
  • Narración de audiolibros por profesionales, incluidos actores, locutores e incluso los propios autores.
Prueba ahora Firma sin compromiso. Cancele cuando quiera.

Compartir